Zomedica Corp.

NYSEAM:ZOM Stock Report

Market Cap: US$122.8m

Zomedica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:ZOM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Nov 24BuyUS$13,231Anthony BlairIndividual150,000US$0.088
11 Nov 24BuyUS$12,100Johnny PowersIndividual100,000US$0.12
11 Nov 24BuyUS$12,200Larry HeatonIndividual100,000US$0.12
11 Nov 24BuyUS$8,765Larry HeatonIndividual100,000US$0.088
11 Nov 24BuyUS$60,290Russell KlassIndividual500,000US$0.12
08 Nov 24BuyUS$18,450Anthony BlairIndividual150,000US$0.12
05 Sep 24BuyUS$12,500Larry HeatonIndividual100,000US$0.13
28 Aug 24BuyUS$12,900Johnny PowersIndividual100,000US$0.13
20 Aug 24BuyUS$14,200Anthony BlairIndividual100,000US$0.14
12 Jun 24BuyUS$46,529Russell KlassIndividual299,993US$0.16
11 Jun 24BuyUS$105,041Russell KlassIndividual700,007US$0.15
10 Jun 24BuyUS$3,798Peter DonatoIndividual25,000US$0.15
17 May 24BuyUS$22,050Johnny PowersIndividual125,000US$0.18
14 May 24BuyUS$6,981Johnny PowersIndividual50,000US$0.14
13 May 24BuyUS$14,200Larry HeatonIndividual100,000US$0.14
13 May 24BuyUS$21,000Anthony BlairIndividual150,000US$0.14
13 May 24BuyUS$14,000Johnny PowersIndividual100,000US$0.14

Insider Trading Volume

Insider Buying: ZOM insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZOM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,132,4800.728%
Private Companies11,160,0001.14%
Institutions81,033,1918.27%
General Public880,623,99789.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 9.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.93%
The Vanguard Group, Inc.
48,326,991US$6.1m0%no data
1.13%
Rowe Family Gst Trust
11,120,000US$1.4m0%no data
1.01%
Geode Capital Management, LLC
9,929,716US$1.2m3.34%no data
1%
BlackRock, Inc.
9,821,071US$1.2m-0.42%no data
0.36%
State Street Global Advisors, Inc.
3,509,881US$439.8k0%no data
0.25%
Brown Brothers Harriman & Co., Asset Management Arm
2,466,532US$309.1k0%no data
0.25%
Johnny Powers
2,425,000US$303.9k4.3%no data
0.18%
Northern Trust Global Investments
1,797,902US$225.3k0%no data
0.15%
Russell Klass
1,500,050US$188.0k-25%no data
0.11%
Jeffrey Rowe
1,120,480US$140.4k0%no data
0.1%
Kevin Russell
1,000,050US$125.3k0%no data
0.051%
Larry Heaton
500,000US$62.6k25%no data
0.042%
Charles Schwab Investment Management, Inc.
412,334US$51.7k0%no data
0.041%
Anthony Blair
400,000US$50.1k60%no data
0.036%
Orion Portfolio Solutions, LLC
357,151US$44.8k0%no data
0.029%
LPL Financial Corporation, Asset Management Arm
285,975US$35.8k1.09%no data
0.028%
Susquehanna International Group, LLP, Asset Management Arm
277,210US$34.7k49.3%no data
0.026%
Cetera Investment Advisers LLC
258,001US$32.3k0%no data
0.026%
Frazier Financial Advisors, LLC
250,000US$31.3k0%0.02%
0.025%
The Glenmede Trust Company, National Association
243,000US$30.5k0%no data
0.022%
Spire Wealth Management, LLC
220,500US$27.6k-1.64%no data
0.022%
Sequoia Financial Advisors, LLC
214,949US$26.9k0%no data
0.02%
Morgan Stanley, Investment Banking and Brokerage Investments
193,478US$24.2k-2.17%no data
0.018%
Sigma Planning Corporation
180,400US$22.6k0%no data
0.018%
Jane Street Group, LLC, Asset Management Arm
179,074US$22.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 21:28
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zomedica Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert LeBoyerNOBLE Capital Markets, Inc.